STEPHANIE NOWAK: Open Payments
NPI 1700361094 · MELBOURNE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$541 in 19 payments from 11 companies in 2025. Trend: 2023 $90 · 2024 $622 · 2025 $541
Food & beverage: $541
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $232 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Biofrontera Inc. | 2 | $41 |
| UCB, Inc. | 1 | $34 |
| Lilly USA, LLC | 1 | $32 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Incyte Corporation | 1 | $30 |
| Amgen Inc. | 1 | $25 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $23 |
| Arcutis Biotherapeutics, Inc. | 1 | $19 |
Products named: SKYRIZI, COSENTYX, AMELUZ, Bimzelx, TALTZ, SPEVIGO, OPZELURA, OTEZLA.
Industry payments across FL — which companies pay providers there.
